Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST

Posted : Tue, 03 Nov 2009 13:07:27 GMT
Author : Repligen Corporation
Category : Press Release
News Alerts by Email ( click here )
News | Home
WALTHAM, Mass., Nov. 3 MA-Repligen-at-Conf

WALTHAM, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the Merriman Curhan Ford 6th Annual Investor Summit on Tuesday, November 10th, 2009 at 1:40 p.m. EST at the Sofitel New York Hotel, 45 West 44th Street, New York, New York. A live audio webcast of the presentation will be available via Repligen's website at www.repligen.com and will be archived for 30 days following the presentation.

About Repligen Corporation
Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our uncertainty of product revenues and profits, our ability to generate future revenues, our ability to raise additional capital to continue our drug development programs, the success of our clinical trials, our ability to develop and commercialize products, our ability to obtain required regulatory approvals, our compliance with all Food and Drug Administration regulations, our ability to obtain, maintain and protect intellectual property rights for our products, the risk of litigation regarding our intellectual property rights, our limited sales and manufacturing capabilities, our dependence on third-party manufacturers and value added resellers, our ability to hire and retain skilled personnel, our volatile stock price, and other risks detailed in Repligen's filings with the Securities and Exchange Commission. Repligen assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

SOURCE Repligen Corporation


Copyright © 2008 PR Newswire. All rights reserved.

Share/Save/Bookmark

Article : Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

It's Christmas Time in the City: Renaissance Seattle Hotel Announces Holiday Package That Makes Wishes Come True
SEATTLE, Nov. 25 /PRNewswire/ -- Renaissance Seattle Hotel, offering premier skyline views and downtown amenities, announces a new Seattle hotel package that gives back this holiday season - t...

GGP Malls Offer Greater Value, More Incentives to Reward Holiday Shoppers All Season Long
CHICAGO - The gift-giving spirit will remain in full force this holiday season. According to an online survey* conducted by NRNSM, a National Research Network, approximately two-thirds of Americans say the tradition of holiday gift giving remains an important part of their

Ribbon Shows Public Support for Holiday Enforcement and MADD's Campaign to Eliminate Drunk Driving
DENVER, Nov. 25 /PRNewswire-USNewswire/ -- Colorado's Mothers Against Drunk Driving (MADD) announced its 24th annual Tie One On For Safety red ribbon campaign, which offers citizens a way to show support for solutions to drunk driving such as the National Highway Traffic Safety Admin...

Nstein's Sentiment Analysis Key Component for evolve24
Corporate reputation management service leverages Nstein to measure perceptions of Fortune 500 brands; connects reputation scores to bottom line. MONTREAL, Nov. 25 - Nstein Technologies Inc.,

Metabolic Research, Inc. Reports First $2,000,000 Quarter
LAS VEGAS - Metabolic Research, Inc. (OTC: MTBR) reported a 90 percent increas

Regulators in West Virginia and Virginia Make Decisions on Procedural Schedules to Review PATH Project
GREENSBURG, Pa. & COLUMBUS, Ohio - Allegheny Energy, Inc. (NYSE: AYE) and American Electric Power (NYSE: AEP) announced today that regulatory commissions in West Virginia and Virginia issued rulings on procedural schedules for the review of the proposed Potomac-Appalachian

12-Hour Free HIV Testing Marathon at Biscayne “Out of the Closet” to Mark World AIDS Day
MIAMI - AIDS Healthcare Foundation:  

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.